BACKGROUND For people with localised prostate cancer, active treatments are effective but
have significant side effects. Minimally invasive treatments that destroy (or ablate) either the …

Abstract The National Cancer Institute (NCI) Symptom Management and Health-Related
Quality of Life Steering Committee convened four working groups to recommend core sets of …

Purpose Although it is the most powerful predictor of early prostate cancer treatment-related
complications and quality-of-life (QOL) outcomes, most studies do not stratify results by …

OBJECTIVE: To evaluate the long-term efficacy of high-intensity focused ultrasound (HIFU)
therapy for patients with localised prostate cancer. MATERIAL AND METHODS: Patients …

PURPOSE: To compare treatment impact on health-related quality of life (HRQL) in patients
with localized prostate cancer, from before treatment to 2 years after the intervention …

Introduction Gay men with prostate cancer (GMPCa) may have differential health‐related
quality of life (HRQOL) and sexual health outcomes than heterosexual men with prostate …

Purpose To compare the toxicities and cost of proton radiation and stereotactic body
radiotherapy (SBRT) with intensity-modulated radiotherapy (IMRT) for prostate cancer …

Objectives: Stereotactic body radiation therapy (SBRT) yields excellent disease control for
low-and intermediate-risk prostate cancer by delivering high doses of radiation in a small …

PURPOSE: We compared acute and late genitourinary (GU) and gastrointestinal (GI)
toxicities in prostate cancer patients treated with three different high-dose radiation …

Objectives To compare the oncological and functional outcomes reported after radical
retropubic prostatectomy (RRP) versus brachytherapy (BT) in the treatment of low-risk …